Drug Insight: biological effects of botulinum toxin A in the lower urinary tract
Michael B Chancellor*, Clare J Fowler, Apostolos Apostolidis, William C de Groat, Christopher P Smith, George T Somogyi and K Roger Aoki
Correspondence *Department of Urology, William Beaumont Hospital, 438 Medical Office Building, 3535 W. 13 Mile Road, Royal Oak, MI 48073, USA
Email chancellormb@gmail.com
There has been increasing interest in the use of botulinum toxins for urological disorders because they have shown effective modulation in striated muscle. In this Review, Chancellor and colleagues look at the experimental evidence for the use of botulinum toxin type A in the lower urinary tract.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.